1. Home
  2. AMBA vs RCUS Comparison

AMBA vs RCUS Comparison

Compare AMBA & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambarella Inc.

AMBA

Ambarella Inc.

HOLD

Current Price

$68.98

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$22.00

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBA
RCUS
Founded
2004
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
AMBA
RCUS
Price
$68.98
$22.00
Analyst Decision
Strong Buy
Buy
Analyst Count
9
9
Target Price
$97.25
$28.89
AVG Volume (30 Days)
1.1M
1.6M
Earning Date
02-25-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$373,850,000.00
$240,000,000.00
Revenue This Year
$39.65
N/A
Revenue Next Year
$9.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.08
N/A
52 Week Low
$38.86
$6.50
52 Week High
$96.69
$26.40

Technical Indicators

Market Signals
Indicator
AMBA
RCUS
Relative Strength Index (RSI) 44.96 47.16
Support Level $64.00 $20.59
Resistance Level $69.05 $23.40
Average True Range (ATR) 3.29 1.39
MACD -0.33 -0.07
Stochastic Oscillator 29.05 32.38

Price Performance

Historical Comparison
AMBA
RCUS

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: